Various anti-cancer agents were combined with tumor-targeting Salmonella strains to improve their effectiveness, such as TNF-related apoptosis-inducing ligand (TRAIL), pore-forming toxin cytolysin A (CylA), and flagellin subunit (FlaB)22–26. The gene discussed is TNFSF10; the disease is cancer.